Back to search

Article

Melioidosis Vaccines (MeVa): Attitudes to vaccines, melioidosis and clinical trials in key stakeholders in Ubon Ratchathani, Thailand

2023-09-19

Abstract excerpt

<h4>Background: </h4> Melioidosis is a bacterial infection which kills an estimated 89,000 people per year in tropical and sub-tropical regions, chiefly affecting the poorest. Diabetes is the primary risk factor, conferring a 12-fold increase in risk. Despite limited funding compared to other neglected tropical diseases, melioidosis vaccine development has generated several candidates for clinical development. The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b06adbd7-53e3-5b38-822c-63539f13884c
DOI
10.12688/wellcomeopenres.18383.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Melioidosis Vaccines (MeVa): Attitudes to vaccines, melioidosis and clinical trials in key stakeholders in Ubon Ratchathani, ThailandDOI 10.12688/wellcomeopenres.18383.1
Select a neighboring publication to make it the new centre.